UK markets open in 4 hours 55 minutes

NIKKEI 225
38,161.95
-112.10(-0.29%)
HANG SENG
17,831.63
+68.60(+0.39%)
CRUDE OIL
79.24
+0.24(+0.30%)
GOLD FUTURES
2,333.20
+22.20(+0.96%)
DOW
37,903.29
+87.37(+0.23%)
Bitcoin GBP
45,645.27
-2,221.51(-4.64%)

Family finances

Who is the breadwinner in your family and does it matter?

OPKO Health, Inc. (0KCS.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

1.2304

+0.0154

(+1.27%)

At close: 07:12PM BST

Loading interactive chart…

Zacks
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory services business.
Zacks
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
PR Newswire
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.